✦ LIBER ✦

Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24week, double-blind, randomized Phase 3 trial

✍ Scribed by Roth, Eli M.; Taskinen, Marja-Riitta; Ginsberg, Henry N.; Kastelein, John J.P.; Colhoun, Helen M.; Robinson, Jennifer G.; Merlet, Laurence; Pordy, Robert; Baccara-Dinet, Marie T.

Book ID: 125860681
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 586 KB
Volume: 176
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2014.06.049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1124 ORAL Results of a randomized, doubl

1124 ORAL Results of a randomized, double-blind phase II trial of ZD6474 versus gefitinib in patients with NSCLC

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 290 KB

A randomized, double-blind trial compari

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia

✍ Yasushi Saito; Nobuhiro Yamada; Tamio Teramoto; Hiroshige Itakura; Yoshiya Hata; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Efficacy and safety of tigecycline monot

Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial

✍ Sarvajna Sacchidanand; Robert L. Penn; John M. Embil; Maria E. Campos; Daniel Cu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Efficacy and Safety of Once-Daily Linacl

Efficacy and Safety of Once-Daily Linaclotide Administered Orally for 26 Weeks in Patients With IBS-C: Results From a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

✍ William D. Chey; Anthony Lembo; James E. MacDougall; Bernard J. Lavins; Harvey S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Efficacy and safety of canagliflozin ver

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

✍ Cefalu, William T; Leiter, Lawrence A; Yoon, Kun-Ho; Arias, Pablo; Niskanen, Leo 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 489 KB

Rapid Improvements In Patient-Reported O

Rapid Improvements In Patient-Reported Outcomes With Certolizumab Pegol In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis: 24-Week Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study

✍ Sieper, J.; Kivitz, A.; van Tubergen, A.; Deodhar, A.; Coteur, G.; Woltering, F. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB